Martin, D. F., Maguire, M. G., Fine, S. L., Ying, G., Jaffe, G. J., Grunwald, J. E., . . . Ferris, 3. (2020). Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results. Ophthalmology (Rochester, Minn.), 127(4S), S135. https://doi.org/10.1016/j.ophtha.2020.01.029
Citace podle Chicago (17th ed.)Martin, Daniel F., Maureen G. Maguire, Stuart L. Fine, Gui-Shuang Ying, Glenn J. Jaffe, Juan E. Grunwald, Cynthia Toth, Maryann Redford, a 3rd Ferris. "Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results." Ophthalmology (Rochester, Minn.) 127, no. 4S (2020): S135. https://doi.org/10.1016/j.ophtha.2020.01.029.
Citace podle MLA (9th ed.)Martin, Daniel F., et al. "Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration: Two-Year Results." Ophthalmology (Rochester, Minn.), vol. 127, no. 4S, 2020, p. S135, https://doi.org/10.1016/j.ophtha.2020.01.029.